Shortage outlook · by company · read 11 November 2026
Which drugs does B. Braun Medical Inc. have on the FDA shortage list?
B. Braun Medical Inc. has 19 presentations of 7 drugs on the FDA shortage list, 0 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.
B. Braun Medical Inc. has 19 presentations of 7 drugs on the FDA shortage list in 11 November 2026.
The company reported 17 available, 2 with limited availability and 0 unavailable.
Drug by drug, as the company reported it
- Dextrose Monohydrate 5% Injection5 presentations · last updated 10 November 2026
- Amino Acid3 presentations · on the list 5 years and 10 months · last updated 10 November 2026
- Dextrose Monohydrate 10% Injection3 presentations · last updated 19 October 2026
- Lidocaine Hydrochloride (Xylocaine)3 presentations · on the list 12 years and 5 months · last updated 10 November 2026
- Heparin Sodium2 presentations · on the list 8 years and 11 months · last updated 19 October 2026
- Sterile Water2 presentations · on the list 3 years and 1 month · last updated 10 November 2026
- Dextrose Monohydrate 70% Injection1 presentation · last updated 10 November 2026
FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.
Where can you go from here?
Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.